Parkinson Disease: all 4,583 studies
Page 38 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- Study for the Early Diagnosis of Parkinson's DiseaseStatus unknownNCT02283073
- Nilotinib in Cognitively Impaired Parkinson Disease Patients 001CompletedNCT02281474Phase 1
- Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.CompletedNCT02278588
- Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain StimulatorsCompletedNCT02278406Not applicable
- Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's DiseaseStatus unknownNCT02275884Not applicable
- Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s DiseaseStatus unknownNCT02274324Not applicable
- A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's DiseaseCompletedNCT02271503Phase 2
- Exercise Targeting Cognitive Impairment in Parkinson's DiseaseStatus unknownNCT02267785Not applicable
- Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's DiseaseCompletedNCT02267434Phase 1
- Parkinson's Disease Exercise TMS PET StudyTerminatedNCT02265900Not applicable
- Augmenting Treatment Effects of Voice Therapy in Parkinson DiseaseStatus unknownNCT02265315Not applicable
- In Vivo Alzheimer ProteomicsTerminatedNCT02263235Not applicable
- The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's DiseaseCompletedNCT02259049Early Phase 1
- Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted StimulatorsCompletedNCT02256319Phase 4
- Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAsCompletedNCT02253732Not applicable
- Resistance Versus Balance Training in Parkinson's DiseaseCompletedNCT02253563Not applicable
- ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement DisordersActive, not recruitingNCT02252380Not applicable
- Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's DiseaseStatus unknownNCT02251808
- Neuromodulation on Motor Function in Parkinson's DiseaseStatus unknownNCT02250690Not applicable
- Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's DiseaseStatus unknownNCT02249715Not applicable
- Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's DiseaseTerminatedNCT02249559
- Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's DiseaseCompletedNCT02248220
- Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's DiseaseCompletedNCT02248207
- Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's DiseaseCompletedNCT02248181
- Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's DiseaseCompletedNCT02248168
- Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's DiseaseCompletedNCT02243982Early Phase 1
- Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With PramipexoleCompletedNCT02236728
- Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation ImpactCompletedNCT02236286Not applicable
- Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain StimulationCompletedNCT02236260Not applicable
- Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative DisordersCompletedNCT02236065Not applicable
- Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's DiseaseCompletedNCT02233023Phase 4
- Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's DiseaseCompletedNCT02231905Phase 4
- Subthalamic Deep Brain Stimulation Effects on Decision-making Processing in Patients With Parkinson's DiseaseCompletedNCT02231645Not applicable
- The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's DiseaseCompletedNCT02231294
- Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's DiseaseCompletedNCT02231255
- Exercise, Brain Imaging, Cognition, and Gait in ParkinsonismCompletedNCT02231073Not applicable
- Treatment of Apomorphine-induced Skin Reactions: a Pilot StudyTerminatedNCT02230930Phase 2
- High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's DiseaseCompletedNCT02230267Phase 2
- Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's DiseaseCompletedNCT02227355
- Sagene 2014 - Parkinson's Disease and Erectile DysfunctionStatus unknownNCT02225548Phase 4
- Computer-based Cognitive Training for Individuals With Parkinson's DiseaseCompletedNCT02225314Not applicable
- The Effect of Low-frequency rTMS on Motor Function in PD Patients With Freezing of GaitStatus unknownNCT02221544Not applicable
- Expressive Writing for Individuals With Parkinson's Disease and Their CaregiversCompletedNCT02217735Not applicable
- Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars ReticulataCompletedNCT02216435
- Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical ActivityCompletedNCT02216188Phase 1
- The Electrophysiological Investigation of Higher Level Neural Manifestations of Freezing of Gait in Parkinson's Disease PatientCompletedNCT02214251Not applicable
- Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure TherapyCompletedNCT02209363Not applicable
- Ambulosono Rasagiline Musical Walking StudyStatus unknownNCT02207387Not applicable
- Can tDCS Enhance Efficacy of Rehabilitative Intervention for Freezing of Gait in Parkinson's Disease?Status unknownNCT02205216Not applicable
- Respiratory Load Magnitude Estimation in PDCompletedNCT02202057
- Sleep Homeostasis in Parkinson's DiseaseCompletedNCT02200887
- Transcutaneous Electrical Nerve Stimulation (TENS) for Lower Urinary Tract Disorders in Parkinson's SyndromeCompletedNCT02190851Not applicable
- Outcomes Data of Adipose Stem Cells to Treat Parkinson's DiseaseStatus unknownNCT02184546
- Pramipexole in Untreated and Levodopa-treated Parkinson's Disease PatientsCompletedNCT02177357Phase 3
- Cycling in Parkinson's DiseaseTerminatedNCT02175082Not applicable
- The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.CompletedNCT02174250Phase 1
- Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's DiseaseCompletedNCT02172573Phase 3
- Electromyography Signals as Biomarkers for Parkinson's DiseaseCompletedNCT02168504
- Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's DiseaseStatus unknownNCT02164162Not applicable
- Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's DiseaseCompletedNCT02157714Phase 1
- Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's DiseaseStatus unknownNCT02154724Not applicable
- Automated Telehealth Diagnostics for Remote Parkinson MonitoringCompletedNCT02152319Not applicable
- Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) Signals for Healthy Controls Evoked Response Potential (ERP) Signals for Healthy Controls and Patients With Parkinson DiseaseStatus unknownNCT02149498
- Validation of DaTscan for Detection of Parkinson Disease Related DisordersStatus unknownNCT02138682
- Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.CompletedNCT02132052
- Temporal Expectations in Parkinson's DiseaseCompletedNCT02126475
- Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy TitrationCompletedNCT02125825
- ParkinStim: Transcranial Direct Current Stimulation for Parkinson's DiseaseCompletedNCT02125383Not applicable
- Transcranial Low Voltage Pulsed Electromagnetic Fields (T-PEMF) in Patients With Parkinson's DiseaseCompletedNCT02125032Not applicable
- Innovative Measures of Speech and Swallowing Dysfunction in Neurological DisordersCompletedNCT02118805
- Effects of Mental Practice in Gait of Individuals With Parkinson Disease: Randomized Clinical TrialCompletedNCT02118506Not applicable
- Improving Functional Disability and Cognition in Parkinson Disease: Randomized Controlled TrialCompletedNCT02118480Not applicable
- LFP Correlates of Movement DisordersStatus unknownNCT02115802Not applicable
- Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's DiseaseCompletedNCT02112812Not applicable
- Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy VolunteersCompletedNCT02111330Phase 1
- Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's DiseaseCompletedNCT02111122Phase 2
- Helicobacter Pylori Eradication Study in Parkinson's DiseaseCompletedNCT02108704Not applicable
- Effect of Osteopathic Manipulative Medicine on Parkinson DiseaseCompletedNCT02107638Not applicable
- Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and MoodCompletedNCT02104401Phase 1
- Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1
- Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of DiseaseTerminatedNCT02103465Phase 2
- Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic DynamometerCompletedNCT02101528
- MIRT and Rotigotine in the Early Stage of PDStatus unknownNCT02100176
- Effects of a Rehabilitation Treatment on Balance in PD Evaluated With a Stabilometric PlatformStatus unknownNCT02098707
- Analysis of the Parameters Obtained on Stabilometric Platform in Patients With PDStatus unknownNCT02098655
- Hallux Mobilization in Patients With Parkinson's DiseaseCompletedNCT02098642
- Crossover Versus Stabilometric Platform in Parkinson's DiseaseCompletedNCT02098577
- A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease PatientsCompletedNCT02096601Phase 1
- Single Ascending Dose Study of PRX002 in Healthy SubjectsCompletedNCT02095171Phase 1
- An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCompletedNCT02082249Phase 3
- Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBSCompletedNCT02080572
- Cholinergic Nicotinic Receptors and Cognition in PDCompletedNCT02076295
- Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease PatientsCompletedNCT02073981
- Light Therapy in Parkinson's DiseaseCompletedNCT02072642Not applicable
- A Retrospective Study of the Relationship Between White Matter Hyperintensities(WMHs) Within the Cholinergic Pathways and the Cognition of PD Patients After Bilateral STN DBSCompletedNCT02071693
- Local Fields Potentials Recorded From Deep Brain Stimulating ElectrodesCompletedNCT02071446
- Inhibiting COMT in Parkinson's DiseaseWithdrawnNCT02070887
- Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's DiseaseStatus unknownNCT02066571Phase 2
- Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and ParkinsonismCompletedNCT02059733Phase 2
- Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's DiseaseCompletedNCT02055274Phase 1